Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007
about
Recruitment feasibility to a cohort study of endocrine and metabolic health among survivors of childhood brain tumours: a report from the Canadian study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE).Evaluation of Pre-Hematopoietic Cell Transplantation (HCT) Brain MRI and Neurologic Complications of Pediatric Patients Undergoing HCT for Hematologic Malignancies.Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low- and middle-income countriesGeographic Variation in Mortality Among Children and Adolescents Diagnosed With Cancer in Tennessee. Does Race Matter?Economic impact of advanced pediatric cancer on familiesChildhood and adolescent cancer statistics, 2014.Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia.Comparison of survival at adult versus pediatric treatment centers for rare pediatric tumors in an adolescent and young adult (AYA) population in the State of GeorgiaThe UCSC Cancer Genomics Browser: update 2015Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantation.Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009.Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumorsEpidemiologic, Racial and Healthographic Mapping of Delaware Pediatric Cancer: 2004-2014Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States.Racial disparities in renal cell carcinoma: a single-payer healthcare experienceEffectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice.Subclinical Hypothyroidism in Childhood Cancer Survivors.A 50-year journey to cure childhood acute lymphoblastic leukemiaPolymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies.Racial, Ethnic, and Age Differences in the Incidence and Survival of Childhood Cancer in Oklahoma, 1997-2012.Impact of socioeconomic disparities on cause-specific survival of retinoblastomaDevelopment of an in-home standardized end-of-life treatment program for pediatric patients dying of brain tumors.Cancer incidence, morbidity, and survival in Canadian first nation children: a Manitoba population-based study from the cancer in young people in Canada (CYP-C) registry.CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target.Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988-2011: A population-based observational study.Evaluation and Outcome of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia in Dar es Salaam, Tanzania.Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia.Poor bone health at the end of puberty in childhood cancer survivors.Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.Childhood cancer survival in Finland (1953-2010): a nation-wide population-based study.Early deaths in pediatric acute leukemia: a population-based study.Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma.Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system.Differential inequality trends over time in survival among U.S. children with acute lymphoblastic leukemia by race/ethnicity, age at diagnosis, and sex.Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission.Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation.
P2860
Q30582316-2D58B6E0-9A52-4882-AF82-602B5E637E05Q31048274-349A3877-7447-43EC-9567-E2F2D937B07DQ33768839-6A5E2CA4-3814-4247-A470-122096B73985Q33782977-9FC0C74A-B7A9-41C0-8805-47A662A78158Q34240383-66B27F48-43F5-4C52-B20F-FA6F666F1D23Q34401667-61DDDA6F-A3FC-41E1-9BA2-09509C9B7BABQ34747454-58E3E40B-396B-4D36-B850-415CB7D8D4D6Q35008064-1D3FA804-36DC-429D-9119-0EAB7CB278B6Q35253526-8EB5738B-9129-4823-AF6B-52706E337972Q35752737-6E8F5E69-74EE-4F54-B227-F5B5C5FA0BF5Q35788430-BF99F2EE-D8A7-4CE9-8952-114AAEA493C0Q35954508-72D00E66-5B6D-474E-A91E-8EBEDC24D244Q36163029-D6882296-C615-46C8-981B-3186D10FC6CEQ36398704-E346605B-EE2C-4F74-B68A-799CC4698122Q36512994-5B907F93-45A7-4D1A-BDD1-A279DF323705Q36731569-70CD6078-16E4-4B6A-916F-1E7AA0F74C12Q36828419-6B12811A-DF38-45BE-86CC-C7F55CA89795Q36945829-C3DB3C39-9C6F-46F1-9198-ECED3D8F1D80Q37099769-7D4AD9E7-F236-4F53-8E35-F06610D9AF66Q37110184-D9E421F8-60E1-4321-9664-DCE5416D2091Q37166753-083161E3-9441-466B-89E2-DAF0689B38F6Q37413286-B8A478E9-8CE7-4A78-A038-219AC961DC7EQ37429378-17BB4F8C-7708-4799-8FEF-08A28B9C4271Q37560905-357875FB-B365-40B7-B309-BF4EE10FE504Q38096436-498F1F74-5540-4678-93AA-677EA8988E3FQ38194992-F91C28A5-C902-49B9-B6C5-6DCA7F45892CQ38311811-EDE31126-43C9-4A77-A678-84E44A9AF15BQ38415196-A8BAB77A-58B7-4C62-9194-22C1C1F67F3FQ38623368-8E15934F-B3DB-4D56-B80E-144019E98D99Q38840936-1E93E399-B369-4784-992A-088700FA5C11Q39007257-026A1B26-5E4D-4358-ADFF-CA36CD95091CQ39115390-B77B942F-FFF9-4E3E-B547-3E12087DC7F3Q39232609-E2C9B15C-7D62-40B9-823D-7BDDD1060E51Q39340123-BEED29BA-29EA-48C1-B746-32F1BCFC4A0EQ39456225-9CF2BF83-82AC-4424-8B40-B22F33EAFCD0Q39610150-F706FA04-8525-425D-8F39-E94A2E59384EQ40039453-FB249868-ABA3-4E16-B719-8ED0D093D452Q40532505-A02AD90F-3CE3-4132-828B-33BFA9340D5EQ45254762-239A6A66-1EE1-428F-A0C3-38DE8FA761ADQ46152229-691709C3-1290-4581-BF6B-08E4A76701E7
P2860
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Treatment outcomes in black an ...... ch Hospital, 1992 through 2007
@ast
Treatment outcomes in black an ...... ch Hospital, 1992 through 2007
@en
type
label
Treatment outcomes in black an ...... ch Hospital, 1992 through 2007
@ast
Treatment outcomes in black an ...... ch Hospital, 1992 through 2007
@en
prefLabel
Treatment outcomes in black an ...... ch Hospital, 1992 through 2007
@ast
Treatment outcomes in black an ...... ch Hospital, 1992 through 2007
@en
P2093
P2860
P50
P356
P1476
Treatment outcomes in black an ...... ch Hospital, 1992 through 2007
@en
P2093
Alberto S Pappo
Amar Gajjar
Cheng Cheng
Ching-Hon Pui
Deqing Pei
James R Downing
John T Sandlund
Larry E Kun
Melissa M Hudson
Monika L Metzger
P2860
P304
P356
10.1200/JCO.2011.40.8617
P407
P577
2012-04-30T00:00:00Z